Here’s What Analysts Are Saying About Teva Pharmaceutical (TEVA) Post Earnings

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best healthcare stocks under $50 to invest in. Barclays maintained an Overweight rating on Teva Pharmaceutical Industries Limited (NYSE:TEVA) on January 30, adjusting the price target on the stock to $38 from $35. It told investors that it updated the company’s model after the fiscal Q4 report, and expressed confidence in the shares at these levels. Teva Pharmaceutical Industries Limited (TEVA): Among Small-Cap Healthcare Stocks Hedge Funds ...